- NEWS FEATURE
- Clarification 11 March 2019
The CRISPR-baby scandal: what’s next for human gene-editing

Illustration by Mike McQuade; Images: Getty
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 566, 440-442 (2019)
doi: https://doi.org/10.1038/d41586-019-00673-1
Updates & Corrections
-
Clarification 11 March 2019: Since the story was first published, a comment has been added from Michael Deem’s lawyer saying that Deem was not a senior author on the human-gene-editing paper describing He’s experiments.
References
Liang, P. et al. Protein Cell 6, 363–372 (2015).
Tang, L. et al. Mol. Genet. Genom. 292, 525–533 (2017).
Ma, H. et al. Nature 548, 413–419 (2017).
Fogarty, N. M. E. et al. Nature 550, 67–73 (2017).
Daley, G. Q., Lovell-Badge, R. & Steffann, J. N. Engl. J. Med. https://doi.org/10.1056/NEJMp1900504 (2019).
Charo, R. A. N. Engl. J. Med. https://doi.org/10.1056/NEJMms1817528 (2019).
Lovell-Badge, R. Development 146, dev175778 (2019).